Autopsy report · NCT01089504

Prophylactic Phenobarbital After Neonatal Seizures

“Inadequate rate of enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months before it started.
• Ran for about 4 years 2 months before it stopped.
• 13 participants enrolled.
• Results were posted on the registry 1 year 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

University of Rochester

Sponsor type

University, hospital or other

Conditions

Neonatal Seizures

Interventions

phenobarbital; placebo

Participants

13

Sites

18

Countries

United States

Trials that died the same way

• Quality of Life Outcomes in Spinal Cord Stimulation
  “Inadequate enrollment” (92% match in meaning)
• Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1
  “Low rate of enrollment” (89% match in meaning)
• Safety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic Patients
  “Lack of substantial enrollment” (89% match in meaning)
• Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma
  “Insufficient enrollment rate” (87% match in meaning)
• Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell Disease
  “Poor enrollment” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.